Items where Author is "Harish, K. P."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 7.

Kumara, Karthik and Harish, K. P. and Naveen, S. and Tandon, Harmesh C. and Mohana, K. N. and Lokanath, N. K. (2017) Crystal structure studies, Hirshfeld surface analysis and DFT calculations of novel 1-5-(4-methoxy-phenyl)-1,3,4]oxadiazol-2-yl]-piperazine derivatives. Chemical Data Collections, 11-12. 40 - 58. ISSN 2405-8300

Harish, K. P. and Mohana, K. N. and Mallesha, L. and Veeresh, B. (2014) Synthesis and in vivo anticonvulsant activity of 2-methyl-2-3-(5- piperazin-1-yl-1,3,4]oxadiazol-2-yl)-phenyl]-propionitrile derivatives. Archiv der Pharmazie, 347 (4). pp. 256-267. ISSN 0365-6233

Harish, K. P. and Mohana, K. N. and Mallesha, L. (2014) Synthesis of new 2,5-disubstituted-1,3,4-thiadiazole derivatives and their in vivo anticonvulsant activity. Russian Journal of Bioorganic Chemistry, 40 (1). pp. 97-105. ISSN 1608-330X

Harish, K. P. and Mohana, K. N. and Mallesha, L. and Veeresh, B. and Madhava Reddy, B. and Naresh Kumar, N. (2013) Synthesis and evaluation of in vivo anticonvulsant activity of 2,5-disubstituted-1,3,4-oxadiazole derivatives. Letters in Drug Design and Discovery, 10 (8). pp. 783-791.

Harish, K. P. and Mohana, K. N. and Mallesha, L. (2013) Synthesis of indazole substituted-1,3,4-thiadiazoles and their anticonvulsant activity. Drug Invention Today, 5 (2). pp. 92-99. ISSN 0975-7619

Harish, K. P. and Mohana, K. N. (2013) Synthesis of new 2-(2,4-dimethoxyphenyl) -1,3,4- oxadiazoles and their antimicrobial activity. International Journal of Pharma and Bio Sciences, 4 (2). B1046-B1055. ISSN 0975-6299

Harish, K. P. and Mohana, K. N. and Mallesha, L. and Prasanna Kumar, B. N. (2013) Synthesis of novel 1-5-(4-methoxy-phenyl)-1,3,4]oxadiazol-2-yl]-piperazine derivatives and evaluation of their in vivo anticonvulsant activity. European Journal of Medicinal Chemistry, 65. 276 - 283. ISSN 0223-5234

This list was generated on Fri Sep 13 07:20:51 2024 IST.